| |
| |
|
| Insider
Information: |
Royston Aaron |
| Relationship: |
Director, 10% Owner |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,905,430 |
|
|
Indirect Shares
|
8,966,394 |
|
|
| Direct
Value |
$7,278,743 |
|
|
|
Indirect Value
|
$24,606,642 |
|
|
| Total
Shares |
10,871,824 |
|
|
| Total
Value |
$31,885,384 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akero Therapeutics, Inc. |
AKRO |
Director |
2019-06-24 |
0 |
2019-06-24 |
3,954,858 |
Premium* |
|
|
Elevation Oncology, Inc. |
ELEV |
|
2022-05-25 |
1,905,430 |
2021-06-29 |
0 |
Premium* |
|
|
Ventyx Biosciences, Inc. |
VTYX |
Director, 10% Owner |
|
0 |
2021-10-25 |
5,011,536 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELEV |
Elevation Oncology, Inc. |
|
• • • |
2022-05-25 |
4 |
S |
$4.12 |
$2,897,806 |
D/D |
(702,737) |
1,905,430 |
0 |
% |
|
| VTYX |
Ventyx Biosciences, Inc. |
Director |
– • • |
2021-10-25 |
4 |
A |
$0.00 |
$0 |
I/I |
3,684,769 |
3,684,769 |
0 |
- |
|
| VTYX |
Ventyx Biosciences, Inc. |
Director |
– • • |
2021-10-25 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
3,997,269 |
2.25 |
% |
|
| VTYX |
Ventyx Biosciences, Inc. |
Director |
– • • |
2021-10-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,014,267 |
|
- |
|
| ELEV |
Elevation Oncology, Inc. |
10% Owner |
– – • |
2021-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,983,167 |
1,983,167 |
0 |
- |
|
| ELEV |
Elevation Oncology, Inc. |
10% Owner |
– – • |
2021-06-29 |
4 |
B |
$16.00 |
$10,000,000 |
D/D |
625,000 |
2,608,167 |
2.45 |
% |
|
| AKRO |
Akero Therapeutics, Inc. |
Director |
– • – |
2019-06-24 |
4 |
B |
$16.00 |
$4,000,000 |
I/I |
250,000 |
250,000 |
2.1 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
Director |
– • – |
2019-06-24 |
4 |
A |
$0.00 |
$0 |
I/I |
3,704,858 |
3,954,858 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
